StockData
Oscar Health, Inc. logo

Oscar Health, Inc. (OSCR) stock

OSCRNYSEHospital & Medical Service PlansFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026Score 11/3028% above fair value
$30.37−0.42 (-1.36%)

Close on Oct 30, 2026Market cap $9.37BP/E 21.7Yield –

Earnings

Oscar Health's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
Nov 5, 2026
Q3 FY2026 · estimated, before the open
Revenue, Q2 FY2026
$4.90B
+71.1% on a year earlier
EPS, Q2 FY2026
$1.10
-$0.89 a year earlier
Latest guidance
Raised
Aug 6, 2026 · 4 items

Quarterly results

Revenue and earnings per share from each of Oscar Health's earnings releases, newest first

QuarterReportedRevenueYoYEPSSource
Q3 FY2026ended Sep 30, 2026Nov 5, 2026Expected––––
Q2 FY2026ended Jun 30, 2026Aug 6, 2026before the open$4.90B+71.1%$1.10Release
Q1 FY2026ended Mar 31, 2026May 6, 2026before the open$4.60B+53.3%$2.07Release
Q4 FY2025ended Dec 31, 2025Feb 10, 2026before the open$2.81B+17.3%-$1.24Release
Q3 FY2025ended Sep 30, 2025Nov 6, 2025before the open$2.99B+24.4%-$0.53Release
Q2 FY2025ended Jun 30, 2025Aug 6, 2025before the open$2.86B+30.2%-$0.89Release
Q1 FY2025ended Mar 31, 2025May 7, 2025before the open$3.00B+42.9%$0.92Release
Q4 FY2024ended Dec 31, 2024Feb 4, 2025after the close$2.39B–-$0.62Release
Q3 FY2024ended Sep 30, 2024Nov 7, 2024before the open$2.40B+66.7%-$0.22Release
Q2 FY2024ended Jun 30, 2024Aug 7, 2024before the open$2.20B+44.6%$0.20Release
Q1 FY2024ended Mar 31, 2024May 7, 2024before the open$2.10B+42.9%$0.62Release
Q4 FY2023ended Dec 31, 2023Jan 10, 2024before the open–––Filing

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Current guidance

Oscar Health's latest outlook for periods it has not reported yet, compared with what it said before

MetricPeriodGuidanceBeforeChangeGiven
Total RevenueFY2026$18.70B – $19.00B$18.70B – $19.00BReaffirmedAug 6, 2026
Earnings from OperationsFY2026$500.00M – $700.00M$250.00M – $450.00MRaisedAug 6, 2026
Medical Loss RatioFY202681.5% – 82.5%82.4% – 83.4%RaisedAug 6, 2026
SG&A Expense RatioFY202615.6% – 16.1%15.8% – 16.3%LoweredAug 6, 2026

Guidance vs results

The last range Oscar Health gave before each report, against the figure it then reported. Full years add up the four quarters.

PeriodMetricGuidanceActualResult
FY2025Revenue$12.00B – $12.20B$11.66BΣ4QBelow range

Guidance history

Every forecast Oscar Health put in an earnings release, newest first

GivenMetricPeriodGuidanceChange
Aug 6, 2026Earnings from OperationsFY2026$500.00M – $700.00MRaised
Aug 6, 2026Medical Loss RatioFY202681.5% – 82.5%Raised
Aug 6, 2026SG&A Expense RatioFY202615.6% – 16.1%Lowered
Aug 6, 2026Total RevenueFY2026$18.70B – $19.00BReaffirmed
Feb 10, 2026Earnings from OperationsFY2026$250.00M – $450.00MNew
Feb 10, 2026Medical Loss RatioFY202682.4% – 83.4%New
Feb 10, 2026SG&A Expense RatioFY202615.8% – 16.3%Lowered
Feb 10, 2026Total RevenueFY2026$18.70B – $19.00BNew
Nov 6, 2025Loss from OperationsFY2025-$300.00M – -$200.00MNew
Nov 6, 2025Medical Loss RatioFY202586% – 87%New
Nov 6, 2025SG&A Expense RatioFY202517.1% – 17.6%Lowered
Nov 6, 2025Total RevenueFY2025$12.00B – $12.20BNew
Jul 22, 2025Loss from OperationsFY2025-$300.00M – -$200.00MNew
Jul 22, 2025Medical Loss RatioFY202586% – 87%Raised
Jul 22, 2025SG&A Expense RatioFY202517.1% – 17.6%Lowered
Jul 22, 2025Total RevenueFY2025$12.00B – $12.20BNew
Feb 4, 2025Earnings from OperationsFY2025$225.00M – $275.00MNew
Feb 4, 2025Medical Loss RatioFY202580.7% – 81.7%New
Feb 4, 2025SG&A Expense RatioFY202517.6% – 18.1%Lowered
Feb 4, 2025Total RevenueFY2025$11.20B – $11.30BNew

Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.

Press releases

Releases Oscar Health filed with the SEC as exhibits to Form 8-K or 6-K

  1. Oscar Health Announces Record Financial Results for First Half 2026 and Raises Full Year 2026 Outlook
    Results
  2. Oscar Health Announces Strong Financial Results for First Quarter 2026 And Reaffirms 2026 Guidance
    Results
  3. Oscar Health, Inc. Appoints Director Siddhartha Sankaran as Independent Chair of the Board
    Update
  4. Oscar Health Announces Financial Results for Fourth Quarter and Full-Year 2025
    Results
  5. Oscar Health Announces Financial Results for Third Quarter 2025 and Reaffirms 2025 Guidance
    Results
  6. $355,000,000 Convertible Senior Subordinated Notes Offering to Scale Long-Term Growth and Consumer and Employer Adoption of the Individual Market
    News
  7. Convertible Senior Subordinated Notes Offering to Scale Long-Term Growth and Consumer and Employer Adoption of the Individual Market
    Update
  8. Oscar Health Announces Financial Results for Second Quarter 2025 and Reaffirms Updated 2025 Guidance
    Results
  9. Oscar Health Announces Preliminary Financial Results for Second Quarter 2025 and Revises 2025 Guidance
    Results
  10. Oscar Health Announces Strong Financial Results for First Quarter 2025 And Reaffirms 2025 Guidance
    Results
  11. Oscar Health Announces Fourth Quarter and Full Year 2024 Results; Introduces Full Year 2025 Outlook
    Results
  12. Oscar Health Announces Results for Third Quarter 2024
    Results
  13. Oscar Health Announces Results for Second Quarter 2024 and Raises Full Year Revenue and Adjusted EBITDA Outlook
    Results
  14. Oscar Health Announces Results for First Quarter 2024
    Results
  15. Quarterly results release
    Results